Plasma levels of 5-hydroxyindole-3-acetic acid (5HIAA) as a pharmacodynamic marker of blood flow changes induced by the vascular targeting agent (VTA) 5,6 dimethyl xanthenone acetic acid, DMXAA ...
A review has shed light on the groundbreaking advancements in the simulation of blood flow within the intricate vascular system that could transform medical treatment and device innovation for ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
A review has shed light on the groundbreaking advancements in the simulation of blood flow within the intricate vascular system that could transform medical treatment and device innovation for ...